Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€3.73
25.04.24
-
25.04.25
2.28%
07:24

Risky Investment
Global_Player 
25.04.24 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
25.04.24
-
25.04.25
-1.53%
07:24

Could be worthwhile Investment >10% per year
Global_Player 
25.04.24 50%
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€2.68
24.04.24
-
24.04.25
2.01%
26.04.24

Could be worthwhile Investment >10% per year
Vassago1 
24.04.24 50%
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.49
23.04.24
€3.00
23.04.25
-9.36%
01:00

Good rating
Growths much faster than the competition
Leading role in innovation
Very good company culture
skatcup 
23.04.24 80%
buy
Viracta Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.81
15.04.24
€3.00
31.10.25
-
15.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
15.04.24 60%
sell
Inotiv Inc.

Start price
Target price
Perf. (%)
€5.50
13.04.24
€4.00
13.04.25
-31.27%
01:00

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
nvestor 
13.04.24 50%
sell
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€22.07
13.04.24
€2.00
13.04.25
-5.48%
01:00

Probably not worthwhile Investment
EBIT decline/stagnation expected
negative Cash Flow expected
Bad rating
nvestor 
13.04.24 50%
buy
Snap-On Inc.

Start price
Target price
Perf. (%)
€271.90
12.04.24
-
12.04.25
0.11%
13.04.24

Finanzoo 
12.04.24 50%
sell
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.50
11.04.24
-
11.04.25
3.27%
14.04.24

Risky Investment
Global_Player 
11.04.24 50%
buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€484.15
11.04.24
-
11.04.25
-1.43%
13.04.24

Finanzoo 
11.04.24 50%
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.91
08.04.24
€3.00
08.04.25
-22.47%
08:33

Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Traumtanz 
08.04.24 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€66.50
07.04.24
-
07.04.25
0.75%
14.04.24

Could be very worthwhile Investment >20% year
Vassago1 
07.04.24 50%
buy
Advanced Micro Devices Inc.

Start price
Target price
Perf. (%)
€163.46
04.04.24
€165.00
04.04.25
-10.02%
08:34

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
Traumtanz 
04.04.24 50%
buy
Qualcomm Inc.

Start price
Target price
Perf. (%)
€160.66
04.04.24
-
04.04.25
-0.09%
13.04.24

Finanzoo 
04.04.24 50%
buy
Cal-Maine Foods Inc.

Start price
Target price
Perf. (%)
€55.84
04.04.24
-
04.04.25
2.94%
13.04.24

Finanzoo 
04.04.24 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.11
02.04.24
-
02.04.25
-38.74%
16.04.24

Could be very worthwhile Investment >20% year
thomasw 
02.04.24 50%
buy
BioXcel Therapeutics Inc

Start price
Target price
Perf. (%)
€2.44
02.04.24
-
02.04.25
14.60%
13.04.24

Could be worthwhile Investment >10% per year
melinda 
02.04.24 10%
buy
ABM Industries Inc.

Start price
Target price
Perf. (%)
€41.20
02.04.24
-
02.04.25
0.97%
13.04.24

Could be worthwhile Investment >10% per year
melinda 
02.04.24 10%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.14
02.04.24
-
02.04.25
-28.14%
13.04.24

Could be worthwhile Investment >10% per year
melinda 
02.04.24 10%
sell
Coeur Mining Inc.

Start price
Target price
Perf. (%)
€3.88
02.04.24
€3.00
02.04.25
15.95%
13.04.24

Probably not worthwhile Investment
High valuation
EBIT decline/stagnation expected
Revenue decline/stagnation expected
kostojunior 
02.04.24 0%
sell
Occidental Petroleum Corp.

Start price
Target price
Perf. (%)
€61.99
02.04.24
€55.00
02.04.25
5.50%
13.04.24

Probably not worthwhile Investment
Low dividend yield expected
Lower EBIT Margin than peer group
Revenue decline/stagnation expected
kostojunior 
02.04.24 20%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.60
02.04.24
-
02.04.25
-48.88%
13.04.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
kostojunior 
02.04.24 0%
buy
Thor Industries Inc.

Start price
Target price
Perf. (%)
€94.04
29.03.24
-
29.03.25
-
30.03.24

Finanzoo 
29.03.24 50%
buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€166.46
28.03.24
€170.00
28.03.25
4.79%
14.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
Traumtanz 
28.03.24 50%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.64
28.03.24
-
28.03.25
-40.27%
31.03.24

Risky Investment
Vassago1 
28.03.24 50%